These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 6228516

  • 1. Inhibition of classical C5 convertase in the complement system by factor H.
    Ito S, Tamura N.
    Immunology; 1983 Dec; 50(4):631-5. PubMed ID: 6228516
    [Abstract] [Full Text] [Related]

  • 2. Regulation of C5 convertase activity by properdin, factors B and H.
    Weiler JM.
    Immunol Res; 1989 Dec; 8(4):305-15. PubMed ID: 2531781
    [No Abstract] [Full Text] [Related]

  • 3. A circulating inhibitor of fluid-phase amplification. C3 convertase formation in systemic lupus erythematosus.
    Waldo FB, Forristal J, Beischel L, West CD.
    J Clin Invest; 1985 Jun; 75(6):1786-95. PubMed ID: 3159752
    [Abstract] [Full Text] [Related]

  • 4. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
    Fischer E, Kazatchkine MD, Mecarelli-Halbwachs L.
    Eur J Immunol; 1984 Dec; 14(12):1111-4. PubMed ID: 6240408
    [Abstract] [Full Text] [Related]

  • 5. Covalent association of C3b with C4b within C5 convertase of the classical complement pathway.
    Takata Y, Kinoshita T, Kozono H, Takeda J, Tanaka E, Hong K, Inoue K.
    J Exp Med; 1987 Jun 01; 165(6):1494-507. PubMed ID: 3495629
    [Abstract] [Full Text] [Related]

  • 6. Surface-dependent modulation by H of C5 cleavage by the cell-bound alternative pathway C5 convertase of human complement.
    Fischer E, Kazatchkine MD.
    J Immunol; 1983 Jun 01; 130(6):2821-4. PubMed ID: 6222117
    [Abstract] [Full Text] [Related]

  • 7. The low C5 convertase activity of the C4A6 allotype of human complement component C4.
    Kinoshita T, Dodds AW, Law SK, Inoue K.
    Biochem J; 1989 Aug 01; 261(3):743-8. PubMed ID: 2803239
    [Abstract] [Full Text] [Related]

  • 8. Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator.
    Gigli I, Fujita T, Nussenzweig V.
    Proc Natl Acad Sci U S A; 1979 Dec 01; 76(12):6596-600. PubMed ID: 293746
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of the alternative C3 convertase and classical C5 convertase of complement by group A streptococcal M protein.
    Hong K, Kinoshita T, Takeda J, Kozono H, Pramoonjago P, Kim YU, Inoue K.
    Infect Immun; 1990 Aug 01; 58(8):2535-41. PubMed ID: 2142480
    [Abstract] [Full Text] [Related]

  • 10. Regulation of the C3 nephritic factor stabilized C3/C5 convertase of complement by purified human erythrocyte C3b receptor.
    Daha MR, Kok DJ, Van Es LA.
    Clin Exp Immunol; 1982 Oct 01; 50(1):209-14. PubMed ID: 6216999
    [Abstract] [Full Text] [Related]

  • 11. Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane.
    Fearon DT.
    Proc Natl Acad Sci U S A; 1979 Nov 01; 76(11):5867-71. PubMed ID: 293688
    [Abstract] [Full Text] [Related]

  • 12. Purification and functional analysis of the polymorphic variants of the C3b/C4b receptor (CR1) and comparison with H, C4b-binding protein (C4bp), and decay accelerating factor (DAF).
    Seya T, Holers VM, Atkinson JP.
    J Immunol; 1985 Oct 01; 135(4):2661-7. PubMed ID: 3161944
    [Abstract] [Full Text] [Related]

  • 13. The interaction of C5 with C3b in free solution: a sufficient condition for cleavage by a fluid phase C3/C5 convertase.
    Isenman DE, Podack ER, Cooper NR.
    J Immunol; 1980 Jan 01; 124(1):326-31. PubMed ID: 7350230
    [Abstract] [Full Text] [Related]

  • 14. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ, Ramsey J, Hammer CH, Frank MM.
    J Immunol; 1983 Jul 01; 131(1):403-8. PubMed ID: 6602833
    [Abstract] [Full Text] [Related]

  • 15. Residual hemolytic and proteolytic activity expressed by Bb after decay-dissociation of C3b,Bb.
    Fishelson Z, Müller-Eberhard HJ.
    J Immunol; 1984 Mar 01; 132(3):1425-9. PubMed ID: 6229580
    [Abstract] [Full Text] [Related]

  • 16. Eosinophil granule major basic protein regulates generation of classical and alternative-amplification pathway C3 convertases in vitro.
    Weiler JM, Gleich GJ.
    J Immunol; 1988 Mar 01; 140(5):1605-10. PubMed ID: 3346544
    [Abstract] [Full Text] [Related]

  • 17. Localization of the covalent C3b-binding site on C4b within the complement classical pathway C5 convertase, C4b2a3b.
    Kozono H, Kinoshita T, Kim YU, Takata-Kozono Y, Tsunasawa S, Sakiyama F, Takeda J, Hong K, Inoue K.
    J Biol Chem; 1990 Aug 25; 265(24):14444-9. PubMed ID: 2387864
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of complement by covalent attachment of rosmarinic acid to activated C3b.
    Sahu A, Rawal N, Pangburn MK.
    Biochem Pharmacol; 1999 Jun 15; 57(12):1439-46. PubMed ID: 10353266
    [Abstract] [Full Text] [Related]

  • 19. In vitro inhibition of the classical pathway of human complement by a natural microbial product, colistin sulphate.
    Asghar SS, de Koster A, van der Helm HJ.
    Biochem Pharmacol; 1986 Sep 01; 35(17):2917-21. PubMed ID: 3638137
    [Abstract] [Full Text] [Related]

  • 20. Differences between the binding sites of the complement regulatory proteins DAF, CR1, and factor H on C3 convertases.
    Pangburn MK.
    J Immunol; 1986 Mar 15; 136(6):2216-21. PubMed ID: 2419425
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.